|
Match
|
Document |
Document Title |
|
|
US20100166874 |
Technology for Preparation of Macromolecular Microspheres
Microspheres are produced by contacting an aqueous solution of a protein or other macromolecule with an organic solvent and a counterion, and chilling the solution. The microspheres are useful for... |
|
|
US20170027855 |
COSMETIC
A composition is provided that includes a fish spawn protein isolate. A natural product extract is also present that includes unsaturated fatty acids and sterols. An emulsifier is provided to form... |
|
|
US20150216807 |
SOLUBILIZED COQ-10
The present invention is directed to compositions and methods of delivery of CoQ-10 solubilized in monoterpenes. Use of monoterpenes as dissolving agents, greatly effects the ability to... |
|
|
US20150037309 |
PREPARATION FOR IMPROVING THE ACTION OF RECEPTORS
The present invention relates to the use of polyunsaturated fatty acids andone or more components which have a beneficial effect on total methioninemetabolism selected from the group consisting of... |
|
|
US20140294796 |
AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
The disclosure provides compositions and methods relating to aromatic-cationic peptides. The methods comprise administering to the subject an effective amount of an aromatic-cationic peptide to... |
|
|
US20140255372 |
CO-ENZYME Q10 FORMULATIONS AND METHODS OF USE
Topical formulations of CoQ10 reduce the rate of tumor growth in an animal subject. In the experiments described herein, CoQ10 was shown to increase the rate of apoptosis in a culture of skin... |
|
|
US20140234410 |
COMBINATION PRODUCTS
A pharmaceutical formulation comprises a plurality of seamless minicapsules having a diameter from 0.5 mm to 5 mm, at least some of the minicapsules containing a methyxanthine as one active... |
|
|
US20140105995 |
SILK FIBROIN SYSTEMS FOR ANTIBIOTIC DELIVERY
The present invention provides for silk fibroin-based compositions comprising one or more antibiotic agents for prevention or treatment of microbial contamination, methods of making... |
|
|
US20130273116 |
ANTI-FOULING COMPOSITION COMPRISING AN AEROGEL
The present invention also relates to an anti-fouling composition comprising one or more aerogels. In one embodiment the aerogel encapsulate one or more bioactive agents. The one or more... |
|
|
US20120201875 |
STABLE LOW DIGESTIVE ENZYME CONTENT FORMULATION
The present invention is directed to a pharmaceutical composition or dosage form having a stable, low (diluted) digestive enzyme content comprising at least one digestive enzyme and at least one... |
|
|
US20120177720 |
MULTI-LAYER WOUND DRESSINGS
A wound dressing includes one or more layers containing a first anti-microbial agent and optionally at least one of: a chelating agent, a second anti-microbial agent, a zinc-containing agent, a... |
|
|
US20120141391 |
Use of creatine or creatine compounds for skin preservation
The present invention relates to the use of creatine compounds such as, for example, creatine, creatine phosphate or analogs of creatine, such as creatine-pyruvate, creatine-ascorbate,... |
|
|
US20120141380 |
POLYMER NANOPARTICLES COATED BY MAGNETIC METAL OXIDE AND USES THEREOF
The invention provides nanoparticles consisting of a polymer which is a metal chelating agent coated with a magnetic metal oxide, wherein at least one active agent is covalently bound to the... |
|
|
US20120036599 |
NOVEL FUNGAL ENZYMES
This invention relates to novel enzymes and novel methods for producing the same. More specifically this invention relates to a variety of fungal enzymes. Nucleic acid molecules encoding such... |
|
|
US20120030838 |
NOVEL FUNGAL ENZYMES
This invention relates to novel enzymes and novel methods for producing the same. More specifically this invention relates to a variety of fungal enzymes. Nucleic acid molecules encoding such... |
|
|
US20110300083 |
PERSONAL CARE FORMULATIONS CONTAINING ALKYL KETAL ESTERS AND METHODS OF MANUFACTURE
Personal care formulations containing alkyl ketal esters having the structure wherein a is 0 or an integer of 1 to 12; b is 0 or 1; R2 is a divalent C1-8 group optionally substituted with up to 5... |
|
|
US20110293539 |
FILM CONTAINING COMPOSITIONS
An oral care, personal care or cleansing composition with a carrier comprising a functional material and at least two polymers. One polymer has a greater solubility in water than the other... |
|
|
US20110229554 |
INTRAVENOUS FORMULATIONS OF COENZYME Q10 (CoQ10) AND METHODS OF USE THEREOF
Disclosed herein are formulations suitable for parenteral administration of certain hydrophobic active agents such as Coenzyme Q10. Methods of preparing the same and methods of treatment of... |
|
|
US20110046606 |
Catheter injectable depot compositions and uses thereof
Catheter injectable depot compositions are provided that include a bioerodible, biocompatible polymer, a solvent having miscibility in water of less than or equal to 7 wt. % at 25° C., in an... |
|
|
US20110027247 |
METHODS FOR TREATMENT OF ONCOLOGICAL DISORDERS USING AN EPIMETABOLIC SHIFTER (COENZYME Q10)
Methods and formulations for treating oncological disorders in humans using Coenzyme Q10 are described. |
|
|
US20100260858 |
DRUG DELIVERY COMPOSITION
A composition for delivery of a drug is disclosed. The composition has a semipermeable coating, particles of a medicament having an effective average particle size of less than or about 2 μm and... |
|
|
US20080193546 |
SOLID DOSE DELIVERY VEHICLE AND METHODS OF MAKING SAME
The present invention encompasses a solid dose delivery vehicle for ballistic administration of a bioactive material to subcutaneous and intradermal tissue, the delivery vehicle being sized and... |
|
|
US20080050311 |
Monoclonal Antibody hPAM4
This invention relates to monovalent and multivalent, monospecific antibodies and to multivalent, multispecific antibodies. One embodiment of these antibodies has one or more identical binding... |
|
|
US20060198831 |
Nitrosylation of protein SH groups and amino acid residues as a therapeutic modality
Nitrosylation of proteins and amino acid groups enables selective regulation of protein function, and also endows the proteins and amino acids with additional smooth muscle relaxant and platelet... |
|
|
US20060182728 |
Methods for treating pervasive development disorders
A method of utilizing the chymotrypsin level of an individual as a measure of the success of secretin, other neuropeptides, and peptides or digestive enzyme administration to such individuals, and... |
|
|
US20060083730 |
Method for treatment of osteochondral and bone defects using an acellular matrix implant
An acellular matrix implant for treatment of defects and injuries of articular cartilage, bone or osteochondral bone and a method for treatment of injured, damaged, diseased or aged articular... |
|
|
US20060083729 |
Biocompatible tissue sealant for treatment of osteochondral and bone defects using an acellular matrix implant
An acellular matrix implant for treatment of defects and injuries of articular cartilage, bone or osteochondral bone and a method for treatment of injured, damaged, diseased or aged articular... |
|
|
US20060083728 |
Acellular matrix implant for treatment of cartilage lesions, injuries and defects
An acellular matrix implant for treatment of defects and injuries of articular cartilage, bone or osteochondral bone and a method for treatment of injured, damaged, diseased or aged articular... |
|
|
US20050089515 |
Poly-pegylated protease inhibitors
Disclosed are compounds that comprise: (i) a Kunitz domain polypeptide that comprises a Kunitz domain that binds to and inhibits a protease; and (ii) a plurality of polyethylene glycol moieties... |
|
|
US20170027914 |
NOVEL ANTI-AGING AGENTS AND METHODS TO IDENTIFY THEM
The present invention discloses novel mechanisms in the aging process and describes novel methods for high-throughput screening to identify, detect, and purify agents to be used for improving... |
|
|
US20160128944 |
COATED PARTICLES AND COMPOSITIONS COMPRISING SAME
The invention provides species of lipid, protein, and/or cationic molecule coated active agents and compositions comprising the coated particles. The compositions can be personal care compositions... |
|
|
US20150086625 |
NUTRACEUTICALS CONTAINING NITRO FATTY ACIDS
Activated fatty acids, nutraceutical compositions including activated fatty acids, methods for using activated fatty acids to treat a variety of diseases, and methods for preparing activated fatty... |
|
|
US20150010614 |
METHODS AND USE OF INDUCING APOPTOSIS IN CANCER CELLS
The present disclosure relates to a method of inducing apoptosis in a cancer cell by delivery of exogenous Coenzyme Q1O or its metabolites thereof in a pharmaceutically acceptable carrier to... |
|
|
US20140301976 |
NOVEL HYDROXAMATES AS THERAPEUTIC AGENTS
The present invention is directed to certain hydroxamate derivatives that are useful in the treatment of hepatitis C. These compounds are also inhibitors of histone deacetylase and are therefore... |
|
|
US20140248223 |
FILM COMPOSITIONS FOR DELIVERY OF ACTIVES
The invention relates to the film products and methods of their preparation that demonstrate a non-self-aggregating uniform heterogeneity. Desirably, the films disintegrate in water and may be... |
|
|
US20140056863 |
NUTRITIONAL COMPOSITIONS HAVING ALPHA-HICA AND EICOSAPENTAENOIC ACID
Nutritional compositions for maximizing muscle protein synthesis while minimizing the catabolism of muscle proteins and methods of using same are provided. In this manner, the nutritional... |
|
|
US20140056862 |
NUTRITIONAL COMPOSITIONS HAVING ALPHA-HICA AND ALPHA-KETOGLUTARATE
Nutritional compositions for maximizing muscle protein synthesis while minimizing the catabolism of muscle proteins and methods of using same are provided. In this manner, the nutritional... |
|
|
US20140037604 |
NUTRITIONAL COMPOSITIONS COMPRISING ALPHA-HYDROXYISOCAPROIC ACID
Nutritional compositions for maximizing muscle protein synthesis while minimizing the catabolism of muscle proteins and methods of using same are provided. In this manner, the nutritional... |
|
|
US20130323187 |
SYNTHETIC PEPTIDES FOR USE AS INHIBITORS OF NEUROTRANSMITTER SECRETION AND AS INDUCERS OF CELLULAR RELAXATION
The present invention describes material and methods related to synthetic peptides which block the secretion of neurotransmitters and induce muscle relaxation, and use of said peptides as... |
|
|
US20120321685 |
COMPOSITIONS CONTAINING OILS HAVING A SPECIFIC GRAVITY HIGHER THAN THE SPECIFIC GRAVITY OF WATER
The invention relates to pharmaceutical or cosmetic compositions preferably in the form of microcapsules or microparticles which include at least one active ingredient and an oil or a mixture of... |
|
|
US20110250251 |
Cosmetic Methods And Compositions For Repairing Human Skin
The present invention relates to methods and compositions for repairing adverse effects of the environment, daily stress, sun exposure, or pre-mature aging on human skin, comprising applying to... |
|
|
US20110223153 |
MODIFIED SILK FILMS CONTAINING GLYCEROL
The present invention provides for compositions and methods for preparing aqueous insoluble, ductile, flexible silk fibroin films. The silk films comprise silk fibroin and about 10% to about 50%... |
|
|
US20110200582 |
LIPIDS, LIPID COMPOSITIONS, AND METHODS OF USING THEM
Disclosed are formulation and optimization protocols for delivery of therapeutically effective amounts of biologically active agents to liver, tumors, and/or other cells or tissues. Also provided... |
|
|
US20110182805 |
Nanoparticle fabrication methods, systems, and materials
Nano-particles are molded in nano-scale molds fabricated from non-wetting, low surface energy polymeric materials. The nano-particles can include pharmaceutical compositions, taggants, contrast... |
|
|
US20110150854 |
RIBOSWITCHES, METHODS FOR THEIR USE, AND COMPOSITIONS FOR USE WITH RIBOSWITCHES
It has been discovered that certain natural mRNAs serve as metabolite-sensitive genetic switches wherein the RNA directly binds a small organic molecule. This binding process changes the... |
|
|
US20100329997 |
USE OF CREATINE OR CREATINE COMPOUNDS FOR SKIN PRESERVATION
The present invention relates to the use of creatine compounds such as, for example, creatine, creatine phosphate or analogs of creatine, such as creatine-pyruvate, creatine-ascorbate,... |
|
|
US20100260706 |
COMPOSITIONS AND METHODS FOR IMPROVING PRODUCTION OF RECOMBINANT POLYPEPTIDES
The present invention relates to biologically active polypeptides linked to one or more accessory polypeptides. The present invention also provides recombinant polypeptides including vectors... |
|
|
US20100226870 |
USE OF CREATINE OR CREATINE COMPOUNDS FOR SKIN PRESERVATION
The present invention relates to the use of creatine compounds such as, for example, creatine, creatine phosphate or analogs of creatine, such as creatine-pyruvate, creatine-ascorbate,... |
|
|
US20100047352 |
COMPOSITIONS AND METHODS FOR TREATING EXCESSIVE BLEEDING
The inventive material is a unique family of externally used wound sealants based upon a binding agent of reactive submicron silica particles that, when hydrated, agglomerate in the form of a... |
|
|
US20100047168 |
Soluble Zcytor 11 Cytokine Receptors
Novel polypeptide combinations, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed for soluble zcytor11 receptors that may be used as novel cytokine... |